Dr Mary Collins
University of Cambridge
PRIME: Development by design
Advancing candidate assessment and manufacturable process
Three tracks. One goal: accelerate therapeutic development with manufacturing success in mind.
September 30, 2026 | 9:30 AM – 4:00 PM
Register your interest in attending
A member of our team will be in touch with you shortly to confirm your registration and spot at our event.
By attending, you confirm you are not located in or a national of a sanctioned country or region, are not a restricted party, and acknowledge that this training may include content subject to U.S. and other export control and sanctions laws. Sharing the content, whether verbally, visually, electronically, or via screen-sharing during webinars must comply with these laws. Allowing unauthorized or restricted individuals to view or participate is a violation and may result in civil and/or criminal penalties.
Track A: Candidate & molecule assessment
Is this molecule ready for development?
What to expect?
- Explore strategies for assessing molecule readiness, identifying development risks, and designing with future manufacturability in mind
- Tour Cytiva's process development laboratories and engage directly with Fast Trak™ scientists
Key takeaways
- Assess molecule readiness and identify developability risks early
- Learn strategies for impurity management and chromatography scale-up
- Discover how early development decisions can improve scalability, manufacturability, and long-term program success
Track B: Accelerating process development
Develop better processes, faster.
What to expect?
Join interactive roundtable discussions led by Cytiva scientists and participate in conversation-driven sessions focused on advancing process efficiency, scalability, and manufacturability.
Choose the topics most relevant to your work, including:
- Improving titers
- Bioreactor scale-up modeling
- HCP reduction
- Aggregate control
- High-concentration feeds
- Viral clearance
- Analytical development
Tour Cytiva's process development labs and engage directly with Fast Trak™ scientists to see development strategies and technologies in action.
Key takeaways
- Gain practical insights from Cytiva specialist and industry experience
- Learn about emerging technologies and approaches
- Discover strategies to improve process efficiency, scalability, and manufacturability
- Leave with actionable insights you can apply immediately to your development programs
Track C: mRNA-LNP development & manufacturing readiness
Building robust RNA therapeutic processes from day one.
What to expect?
- Gain insights into mRNA-LNP regulatory considerations, downstream processing challenges, and emerging applications such as in vivo CAR-T
- Experience live equipment demonstrations and discuss development and scale-up strategies with Cytiva experts
Key takeaways
- Understand the critical factors that influence successful mRNA-LNP development, scale-up, and manufacturing readiness
- Gain insights into downstream processing strategies and evolving regulatory considerations for RNA therapeutics
- Explore emerging applications, including in vivo CAR-T, through expert discussions and live equipment demonstrations
Click here to register your track
By participating in the event, you agree that Records of you are taken (photo/audio/video), and that these Records may be used in Cytiva’s future promotional content (e.g., websites, marketing materials, social media, internal communications, etc.). Records are available worldwide when published on the internet. Further use and/or modification by third parties cannot be excluded. Data may also be processed outside of the country of your residence, in jurisdictions that may not offer the same level of protection for personal data. You grant Cytiva royalty-free, worldwide, unlimited license to the usage of the records. You acknowledge and agree that you will not receive any compensation, monetary or otherwise, for the use of records and hereby releases Cytiva from any and all claims which arise out of or are in any way connected with the uses of records as allowed by the applicable laws. You can learn more about your rights and how to exercise them, as well as about how Cytiva processes your personal data, here: https://www.cytivalifesciences.com/legal/privacy. You can withdraw your consent at any time, with the effect for the future, by contacting us ([email protected]).
Why attend PRIME: Development by design?
A promising molecule is only the beginning. Success depends on making informed decisions early, from selecting promising candidate to process development.
At PRIME, you'll choose from three focused tracks tailored to your scientific interests:
- Candidate & molecule assessment
- Accelerating process development
- mRNA-LNP development & manufacturing readiness
Through presentations, discussions, lab tours, and live demonstrations, you'll gain practical approaches to reduce development risk and support manufacturing readiness.
Join fellow scientists and Cytiva specialists for a day of learning, collaboration, and insights to help build better therapeutics from the start.
Who should attend?
- Candidate assessment & discovery scientists
- Process development scientists & engineers
- Purification & downstream development teams
- Cell culture & upstream development scientists
- Process characterization & analytical development teams
- MSAT and technology transfer professionals
- Technical leaders focused on scalable biologic manufacturing
- Scientists advancing candidates from development to commercialization
Agenda
Agenda and schedules are subject to change. All times listed are in EST.
| Time | Details | Location |
|---|---|---|
| 9:30 – 10:00 | Registration and breakfast | DBSU Forum |
| 10:00 – 10:45 | Introduction and welcome "Challenges and industry trends across process development" Alper Uras, Director of PD Technical Consultancy |
DBSU Auditorium |
| 10:45 - 11:45 | First track breakouts: Lab tours | |
| Track A - Customer excellence center Cory O’Brien, Sr BPAS Manager |
CEC | |
| Track B - Fast Trak™ Lab Mohamed Shaker, Lead Scientist |
Fast Trak™ lab | |
| Track C - Process development labs Kayla Ahrens, Scientist |
Process development labs | |
| 11:45 – 12:45 | Lunch & networking | Cytiva forum |
| 12:45 – 1:00 | Transition to track breakouts |
Track A: Candidate & molecule assessment
| Time | Details | Location |
|---|---|---|
| 1:00 – 1:15 | Fast Trak™ presentation TBD |
Martha’s Vineyard |
| 1:15 – 1:30 | Transition to Fast Trak™ tour | |
| 1:30 – 2:30 | Fast Trak™ tour Mohamed Shaker, Lead Scientist |
Fast Trak™ lab |
| 2:30 – 2:45 | Transition to presentations | |
| 2:45 – 3:30 | “Scale your chromatography with confidence: A practical roadmap for column sizing, system selection, and GxP readiness” Caroline Duffy, ÄKTA™ Specialist |
Martha’s Vineyard |
| 3:30 – 4:00 | "Process-related impurity risk mitigation in mAb therapeutic manufacture" Mohamed Shaker, Lead Scientist |
Martha’s Vineyard |
Track B: Accelerating process development
| Time | Details | Location |
|---|---|---|
| 1:00 – 1:45 | Customer excellence center tour Cory O’Brien, Sr BPAS Manager |
CEC |
| 1:45 – 2:00 | Transition to roundtable discussions | |
| 2:00 – 2:40 | First roundtable discussion Moderated discussions around upstream, downstream and analytical development with Cytiva specialists |
DBSU |
| 2:40 – 3:00 | BioBreak | |
| 3:00 – 3:40 | Second roundtable discussion Moderated discussions around upstream, downstream and analytical development with Cytiva specialists |
DBSU |
| 3:40 – 3:45 | Closing remarks |
DBSU |
Track C: mRNA-LNP development & manufacturing readiness
| Time | Details | Location |
|---|---|---|
| 1:00 – 1:30 | “Targeted LNPs for in vivo CAR-T cell therapy: Manufacturing strategies to enable translation to the clinic” Lloyd Jeffs, Strategic Customer Leader |
Boardroom |
| 1:30 – 2:00 | “Process considerations for TFF of LNPs: A data-driven approach for filter selection and scale-up" Divakara Uppu, Senior Scientist |
Boardroom |
| 2:00 – 2:30 | “Regulatory considerations for mRNA-LNP development” Limin Wang, Manager Regulatory Science and Strategy |
Boardroom |
| 2:30 – 2:45 | Transition to lab tour | |
| 2:45 – 4:00 | Live equipment demonstration Cytiva specialists |
CEC |
